OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients
Rianne Brouwer, Peter M. ten Klooster, Joost B. Masselink, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 8
Rianne Brouwer, Peter M. ten Klooster, Joost B. Masselink, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 8
Showing 8 citing articles:
Switching from Adalimumab Reference Product to and Among Adalimumab Biosimilars Outside the USA: Insights for US Clinicians
John Tesser, Aline Charabaty, Adelaide A. Hebert
BioDrugs (2025)
Open Access
John Tesser, Aline Charabaty, Adelaide A. Hebert
BioDrugs (2025)
Open Access
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis
Rouhin Sen, Maria Riofrio, Jasvinder A. Singh
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 6, pp. 687-714
Closed Access | Times Cited: 3
Rouhin Sen, Maria Riofrio, Jasvinder A. Singh
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 6, pp. 687-714
Closed Access | Times Cited: 3
Bacillus coagulans BACO-17 ameliorates in vitro and in vivo progression of Rheumatoid arthritis
Chun-Lin Kuo, Skye Hsin‐Hsien Yeh, Tsung-Ming Chang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112863-112863
Closed Access | Times Cited: 2
Chun-Lin Kuo, Skye Hsin‐Hsien Yeh, Tsung-Ming Chang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112863-112863
Closed Access | Times Cited: 2
Clinical outcomes of switching to adalimumab biosimilar (MSB11022) in patients with rheumatoid arthritis: RESTART Spanish Registry
Javier García-Miguel, Liliya Yankova Komsalova, Cristina Mata Arnaiz, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1431-1438
Closed Access
Javier García-Miguel, Liliya Yankova Komsalova, Cristina Mata Arnaiz, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1431-1438
Closed Access
Bioanalogues in the treatment of rheumatoid arthritis: current status of the problem
Н. В. Чичасова, А. М. Лила
Modern Rheumatology Journal (2024) Vol. 18, Iss. 6, pp. 98-106
Open Access
Н. В. Чичасова, А. М. Лила
Modern Rheumatology Journal (2024) Vol. 18, Iss. 6, pp. 98-106
Open Access
Patient Experience with the SensoReady® Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s Disease
Shrihari Jathanakodi, Charlotte Both, Ines Brueckmann, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 1107-1118
Open Access
Shrihari Jathanakodi, Charlotte Both, Ines Brueckmann, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 1107-1118
Open Access
